Cargando…
Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition
BACKGROUND: Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis when combined with statin. However, side by side comparison has not been made to evaluate the beneficial effects of ezetimibe alone versus statin. Herein, the study aimed to test whether e...
Autores principales: | Tie, Chunmiao, Gao, Kanglu, Zhang, Na, Zhang, Songzhao, Shen, Jiali, Xie, Xiaojie, Wang, Jian-an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640821/ https://www.ncbi.nlm.nih.gov/pubmed/26555472 http://dx.doi.org/10.1371/journal.pone.0142430 |
Ejemplares similares
-
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
por: Wu, Na-Qiong, et al.
Publicado: (2018) -
Efficient aortic lymphatic drainage is necessary for atherosclerosis regression induced by ezetimibe
por: Yeo, Kim Pin, et al.
Publicado: (2020) -
Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008) -
Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
por: Farnier, Michel, et al.
Publicado: (2011) -
Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
por: Huang, Shushi, et al.
Publicado: (2021)